Well‑differentiated neuroendocrine tumor of the right kidney: A case report

Oncol Lett. 2023 Apr 20;25(6):243. doi: 10.3892/ol.2023.13829. eCollection 2023 Jun.

Abstract

Neuroendocrine tumors (NETs) are tumors originating from neuroendocrine cells and peptidergic neurons. Primary renal well-differentiated NETs (WDNETs) are rare and only sporadic cases have been reported worldwide. In November 2021, a 45-year-old female patient was admitted to The Affiliated Hospital of Zunyi Medical University (Zunyi, China) with right-sided lumbago. Abdominal computed tomography revealed a 44×34×70-mm mass in the right kidney. Following a complete examination, a laparoscopic partial nephrectomy of the right kidney was performed under general anesthesia. The postoperative pathology indicated a well-differentiated NET of the right kidney. There was no tumor recurrence or metastasis during the 1-year follow-up period. WDNETs are rare, their clinical and imaging findings are not specific, and their diagnosis depends on immunohistochemical analysis. The degree of malignancy is low and the prognosis is positive. Surgical resection is often the first choice, and long-term follow-up is required.

Keywords: case report; primary renal carcinoid tumors; renal neoplasms; renal neuroendocrine neoplasms; well-differentiated neuroendocrine tumor of the kidney.

Publication types

  • Case Reports

Grants and funding

The current study was supported by the Science and Technology Project of Zunyi City, China (grant no. HZ-2021-11) and Science and Technology Foundation of Guizhou Province, China [grant no. ZK(2022)665].